Scientists test new Drug's safety in first human trial
NCT ID NCT05232175
Summary
This was an early-stage study to check the safety and side effects of a new drug called ALT-BB4 in healthy volunteers. Researchers gave the drug to 290 healthy adults to see how their bodies reacted to it and how the drug was processed. The main goal was to find out if it caused any allergic reactions or problems at the injection site.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH, SUBJECTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.